besides originating from pulmonary neuroendocrine cells (18), SCLC may arise from other lung epithelial cells (19), with type II pneumocytes having the potential to differentiate into both histologies, possibly giving rise to both EGFR-mutant adenocarcinoma and SCLC (20); 3. The gene discussed is EGFR; the disease is adenocarcinoma.